tiprankstipranks
Trending News
More News >
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market

Context Therapeutics (CNTX) Financial Statements

Compare
201 Followers

Context Therapeutics Financial Overview

Context Therapeutics's market cap is currently $147.01M. The company's EPS TTM is $-0.1; its P/E ratio is -5.72; Context Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -29.92M$ -25.07M$ -15.38M$ -10.53M$ -2.57M
EBITDA$ -29.91M$ -25.06M$ -14.87M$ -10.39M$ -2.57M
Net Income$ -26.73M$ -23.96M$ -14.84M$ -10.46M$ 6.64M
Balance Sheet
Cash & Short-Term Investments$ 94.43M$ 14.45M$ 35.50M$ 49.64M$ 341.04K
Total Assets$ 98.13M$ 16.06M$ 37.97M$ 51.31M$ 467.34K
Total Debt$ 219.38K$ 0.00$ 55.08K$ 0.00$ 5.95M
Net Debt$ -94.21M$ -14.45M$ -35.44M$ -49.64M$ 5.61M
Total Liabilities$ 2.86M$ 4.19M$ 3.21M$ 3.03M$ 17.39M
Stockholders' Equity$ 95.27M$ 11.87M$ 34.76M$ 48.27M$ -16.92M
Cash Flow
Free Cash Flow$ -29.31M$ -21.05M$ -14.09M$ -9.05M$ -1.03M
Operating Cash Flow$ -14.56M$ -21.05M$ -13.55M$ -8.80M$ -1.03M
Investing Cash Flow$ -14.76M$ 0.00$ -536.84K$ -250.00K$ 0.00
Financing Cash Flow$ 109.29M$ 0.00$ -102.07K$ 58.39M$ 1.15M
Currency in USD

Context Therapeutics Earnings and Revenue History

Context Therapeutics Debt to Assets

Context Therapeutics Cash Flow

Context Therapeutics Forecast EPS vs Actual EPS